Orthofix Posts 15-Cent Quarterly Loss as Shares Sit Near 52-Week Low
OFIX is trading near its 52-week low of $7.81 (9.2% below the low) on elevated volume (2.0× avg).
Summary
Orthofix reported a third-quarter loss of 15 cents per share, a negative print for a company whose stock is already trading near its 52-week low. The quarter's sales rose 1.1%, and EBITDA increased to $26.0M. The loss comes after Q2 net sales of $210.9M, up 5% on a pro forma constant currency basis, when management raised full-year 2026 guidance and CMS restored Medicare reimbursement for its bone growth stimulator. That makes this quarterly loss a step back from the improving trend the company had been building, and the company revised its full-year 2026 guidance.
At the time of this announcement, OFIX was trading at $7.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $320.6M. The 52-week trading range was $7.81 to $16.42. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.